Improving gastric balloons to treat obesity

Affiliations

¹ Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
² Diabetes Research Centre, Ulster University, Coleraine, UK. Electronic address: carel.leroux@ucd.ie.

Comment

Alexis Sudlow et al. Lancet. 2021.

. 2021 Nov 27;398(10315):1940-1941.

doi: 10.1016/S0140-6736(21)02505-8. Epub 2021 Nov 15.

¹ Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.
² Diabetes Research Centre, Ulster University, Coleraine, UK. Electronic address: carel.leroux@ucd.ie.

Erratum in

Department of Error.
[No authors listed] [No authors listed] Lancet. 2022 Jan 29;399(10323):436. doi: 10.1016/S0140-6736(22)00047-2. Lancet. 2022. PMID: 35093229 No abstract available.

No abstract available

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.
Abu Dayyeh BK, Maselli DB, Rapaka B, Lavin T, Noar M, Hussan H, Chapman CG, Popov V, Jirapinyo P, Acosta A, Vargas EJ, Storm AC, Bazerbachi F, Ryou M, French M, Noria S, Molina D, Thompson CC. Abu Dayyeh BK, et al. Lancet. 2021 Nov 27;398(10315):1965-1973. doi: 10.1016/S0140-6736(21)02394-1. Epub 2021 Nov 15. Lancet. 2021. PMID: 34793746 Clinical Trial.